These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10369303)

  • 1. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases.
    Stangel M; Toyka KV; Gold R
    Arch Neurol; 1999 Jun; 56(6):661-3. PubMed ID: 10369303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-D immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy.
    Vermeulen M; van Schaik IN; Brand A
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):383-4. PubMed ID: 7897433
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.
    Brand A; Van Doorn PA; Rossi F; Kazatchkine MD; Vermeulen M
    Prog Clin Biol Res; 1990; 337():405-9. PubMed ID: 2353004
    [No Abstract]   [Full Text] [Related]  

  • 5. Future developments in the treatment of immune-mediated polyneuropathies.
    van der Meché FG; van Doorn PA
    Eur Neurol; 1997; 38(3):230-7. PubMed ID: 9363836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin in neurological disorders: a mechanistic perspective.
    Misra N; Bayry J; Ephrem A; Dasgupta S; Delignat S; Duong Van Huyen JP; Prost F; Lacroix-Desmazes S; Nicoletti A; Kazatchkine MD; Kaveri SV
    J Neurol; 2005 May; 252 Suppl 1():I1-6. PubMed ID: 15959666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational therapy of Guillain-Barré syndrome.
    Samman I; Wöhrle JC; Hennerici M
    Lancet; 1998 Mar; 351(9104):753-4. PubMed ID: 9504543
    [No Abstract]   [Full Text] [Related]  

  • 8. On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA; Rossi F; Brand A; van Lint M; Vermeulen M; Kazatchkine MD
    J Neuroimmunol; 1990; 29(1-3):57-64. PubMed ID: 2211989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic demyelinating polyneuropathy in pregnancy treated with intravenous immunoglobulin.
    Nwosu EC; Tandon S; Breeze C; Enevoldson TP; Khaleeli AA
    Br J Obstet Gynaecol; 1999 Feb; 106(2):174-6. PubMed ID: 10426685
    [No Abstract]   [Full Text] [Related]  

  • 10. Rational therapy of Guillain-Barré syndrome.
    Berciano J
    Lancet; 1998 Mar; 351(9104):754-5. PubMed ID: 9504544
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.
    Ephrem A; Misra N; Hassan G; Dasgupta S; Delignat S; Duong Van Huyen JP; Chamat S; Prost F; Lacroix-Desmazes S; Kavery SV; Kazatchkine MD
    Clin Exp Med; 2005 Dec; 5(4):135-40. PubMed ID: 16362793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].
    Gold R; Hartung HP; Toyka KV
    Fortschr Neurol Psychiatr; 1995 Jan; 63(1):17-29. PubMed ID: 7883268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
    Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
    Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies?
    van Schaik IN; Vermeulen M; Brand A
    Mult Scler; 1997 Apr; 3(2):98-104. PubMed ID: 9291162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous gammaglobulin for chronic inflammatory demyelinating polyneuropathy.
    Currò Dossi B; Tezzon F
    Ital J Neurol Sci; 1987 Aug; 8(4):321-6. PubMed ID: 3119516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of immune neuropathies with intravenous immunoglobulins.
    Gold R; Kieseier BC
    J Neurol; 2006 Sep; 253 Suppl 5():V59-63. PubMed ID: 16998755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.
    Comi G; Nemni R; Amadio S; Galardi G; Leocani L
    Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.